2024
DOI: 10.21203/rs.3.rs-3883485/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Personalized Therapies in Hepatocellular Carcinoma: Insights from a Disulfidptosis-Related Signature

Yi Wan,
Dan Xu,
Zhiyong Zhou
et al.

Abstract: Hepatocellular carcinoma (HCC) is the predominant pathological type of liver cancer with an unfavorable prognosis. Disulfidptosis is the newest cell death form and plays a vital role in tumorigenesis. However, the role of disulfidptosis-related genes (DRGs) in HCC remains unknown. The RNA-seq and clinical data of HCC patients were obtained from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases. Based on DRGs in TCGA cohort, the predictive model was established via regre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 46 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?